Investing in the future: prevention a priority at last.

Med J Aust

International Public Health Unit, School of Public Health and Preventive Medicine and Research, Australian Institute of Health Policy Studies, Monash University, Melbourne, VIC, Australia.

Published: September 2008

We won't make progress on preventing disease if we don't try. It's time to try!

Download full-text PDF

Source
http://dx.doi.org/10.5694/j.1326-5377.2008.tb02022.xDOI Listing

Publication Analysis

Top Keywords

investing future
4
future prevention
4
prevention priority
4
priority progress
4
progress preventing
4
preventing disease
4
disease it's
4
it's time
4
time try!
4
investing
1

Similar Publications

Identifying and monitoring adverse effects (AEs) are integral to ensuring patient safety in clinical trials. Research sponsors and regulatory bodies have put into place a variety of policies and procedures to guide researchers in protecting patient safety during clinical trials. However, it remains unclear how these policies and procedures should be adapted for trials in implementation science.

View Article and Find Full Text PDF

Assessment of Emphysema on X-ray Equivalent Dose Photon-Counting Detector CT: Evaluation of Visual Scoring and Automated Quantification Algorithms.

Invest Radiol

October 2024

From the Institute for Diagnostic and Interventional Radiology, University Hospital Zurich, University Zurich, Zurich, Switzerland (B.K., F.E., J.K., T.F., L.J.); Advanced Radiology Center, Department of Diagnostic Imaging and Oncological Radiotherapy, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy (C.S., A.R.L.); and Section of Radiology, Department of Radiological and Hematological Sciences, Università Cattolica del Sacro Cuore, Rome, Italy (A.R.L.).

Objectives: The aim of this study was to evaluate the feasibility and efficacy of visual scoring, low-attenuation volume (LAV), and deep learning methods for estimating emphysema extent in x-ray dose photon-counting detector computed tomography (PCD-CT), aiming to explore future dose reduction potentials.

Methods: One hundred one prospectively enrolled patients underwent noncontrast low- and chest x-ray dose CT scans in the same study using PCD-CT. Overall image quality, sharpness, and noise, as well as visual emphysema pattern (no, trace, mild, moderate, confluent, and advanced destructive emphysema; as defined by the Fleischner Society), were independently assessed by 2 experienced radiologists for low- and x-ray dose images, followed by an expert consensus read.

View Article and Find Full Text PDF

Youth-led participatory action research (YPAR) engages young people as partners in rigorous research inquiry to guide and inform collective action. Scholars interested in YPAR have notable investment in social justice and activist values, which at times come in direct tensions within their doctoral training and/or professional roles within academia. One monumental hurdle in conducting YPAR is obtaining approval from the Institutional Review Board (IRB).

View Article and Find Full Text PDF

Background: COVID-19 drastically affected healthcare services world-wide. In the UK, many cancer services were overwhelmed as oncology staff were reassigned, and cancer diagnoses and treatments were delayed. The impact of these pressures on end-of-life care for patients with advanced cancer and their relatives is not well understood.

View Article and Find Full Text PDF

This article presents a planning framework to improve the weather-related resilience of natural gas-dependent electricity distribution systems. The problem is formulated as a two-stage stochastic mixed integer linear programing model. In the first stage, the measures for distribution line hardening, gas-fired distributed generation (DG) placement, electrical energy storage resource allocation, and tie-switch placement are determined.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!